Field Fisher and Penningtons Manches LLP
We are a team of specialist international lawyers and are rated by buyers of our services as the “go to firm” for expertise, commerciality and client care. Our life sciences team, with members across our European offices, provides a broad range of legal assistance to pharmaceutical, biotechnology, medical device, eHealth and medtech companies as well as regulators, care providers and industry associations.
Many of our lawyers are dual qualified and have worked in industry. Our ability to provide tailor-made, bespoke advice with a depth of key regulatory and sector knowledge across our offices sets us apart from the crowd.
Our team provide specialist expertise across:
IP and commercial agreements
Venture capital and funding
Competition and trade
Employment, immigration and pensions advice
Tax, restructuring and reorganisations
Technology, outsourcing and privacy
IP and commercial
Advising companies to establish in Europe, compliantly sell their devices and products and develop relationships.
Successfully defending clients and pursing competitors in IP disputes
Being at the cutting edge of patent law in EPO proceedings.
Advising on joint and strategic development agreements
Advising companies and VC Funds on investment rounds, IP deals and ECM transactions
Obtaining successful outcomes on adverse events and quality issues with competent authorities.
Technology and Data
Advising on genome sequencing of DNA samples of patients with rare diseases and cancer.
Providing data protection advice to clients developing medical device apps.
Our offer to LBIC clients
A free consultation
A discount on fees dependent on the type of work
Capped and contingent fees for investment/funding work
Utilising our offices across the UK and our alternative legal services businesses to deliver you with better value
Access to our training, seminars and legal updates and industry events
Justyna Ostrowska - Solicitor
+44 207 861 4709
Keith Woodhouse - Partner
+44 207 861 6788
Penningtons Manches LLP
Penningtons Manches LLP is a top 50 UK law firm with a special focus on the technology and life sciences sectors. With our head office in the City in London, five other UK regional offices including Oxford and Cambridge and an office in San Francisco, we have close to 400 lawyers covering all areas of law relevant to businesses and organisations based at or relocating to LBIC. Our membership of the Multilaw and European Law Group networks gives us access to top quality legal advice in the USA and all other major jurisdictions.
Our life sciences team advises on:
IP and commercial agreements including research, collaboration, clinical trial, manufacture and supply, out and in licensing agreements and technology transfer at all stages of development
Corporate and business disposals and acquisitions
Equity/venture capital funding transactions, from business angel investments through to major institutional investor deals
Corporate governance and company secretarial
Share options including EMI and growth share and other share schemes
Joint ventures and co-operation agreements
Tax including R&D tax credits and the 'patent box'
Commercial and IP dispute resolution including patent and cross border litigation
IT, digital business and data protection
Employment law and immigration including assistance with sponsor licensing, business visitors and EEA applications
Our lawyers have extensive experience of working with life sciences companies, both in-house and in private practice. Many have technical backgrounds, enabling them to offer a commercially focused and pragmatic approach to our advice.
We act for businesses at all stages of their life cycle, from global pharmaceutical companies to SMEs, numerous growth and early stage companies (including many spun-out from Imperial College and Oxford University), investors, research organisations and universities (including King’s College London).
We have a dedicated venture capital team advising company clients on more than 40 VC funding deals a year, from seed and angel funding through to Series A and B and beyond, including many in the life sciences sector.
Representative transactions include:
advising Immunocore on its multi-million US$ co-discovery and co-development agreement to research and potentially develop new T cell-based cancer therapies with Eli Lilly
advising Veryan Holdings on its £18m Series B funding led by Imperial Innovations and supported by Invesco Asset Management, Seroba Kernel and Seven Mile Capital, to develop Veryan’s 3D stent technology
acting for Adaptimmune on its multi-million US$ strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialisation of its clinical cancer programme
advising Oxford Gene Technology on its acquisition of Cytocell, a leading developer and manufacturer of probes for use in routine cytogenetics and in the analysis and classification of cancers
Our offer to LBIC clients
For current or prospective LBIC tenant clients we offer:
a free initial consultation
a 15% discount on fees for the first year plus a 10% discount on fees for the second year
lower regional (rather than London) fee rates
fixed fees on funding rounds and licensing deals where possible
fully contingent fee deals on early stage funding rounds where possible
participation in our life sciences and other legal know how programmes, including email updates, webinars and seminars